International Patent: INTRANASAL DANTROLENE NANOPARTICLES, ALONE OR IN COMBINATION WITH LITHIUM, FOR TREATING DEPRESSION AND AMYOTROPHIC LATERAL SCLEROSIS (ALS)

GENEVA, Aug. 31 -- THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA filed a patent application (US2026/016152) for “INTRANASAL DANTROLENE NANOPARTICLES, ALONE OR IN COMBINATION WITH LITHIUM, FOR TREATING DEPRESSION AND AMYOTROPHIC LATERAL SCLEROSIS (ALS)”. With publication no. WO/2026/178437, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: none

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....